Skip to content

Ultrasound-Guided Intermediate Cervical Plexus or Cervical Erector Spinae Block for Anterior Cervical Spine Surgery

Regional Analgesia Using Ultrasound-Guided Intermediate Cervical Plexus Block or Cervical Erector Spinae Block for Anterior Cervical Spine Surgery: A Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05577559
Enrollment
58
Registered
2022-10-13
Start date
2022-11-01
Completion date
2023-12-01
Last updated
2023-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Brief summary

• Neck pain and stiffness or sore throat, are common after anterior cervical spine surgery. Complications are rare but can be serious and even potentially life-threatening if they do occur. Rapid recovery and emergence from general anesthesia are important in cases of anterior cervical spine surgery.

Detailed description

* Null hypothesis (H0): No difference between the regional analgesia effects of bilateral ultrasound-guided superficial cervical plexus block and bilateral cervical erector spinae block in patients undergoing anterior cervical spine surgery under general anesthesia. * Alternative hypothesis (H1): There are differences between the regional analgesia effects of bilateral ultrasound-guided superficial cervical plexus block and bilateral cervical erector spinae block in

Interventions

patients will receive bilateral ultrasound guided intermediate cervical plexus block using 15 ml of bupivacaine 0.25% for each side.

PROCEDURECervical Erector spinae block

patients will receive bilateral ultrasound guided cervical erector spinae plane block using 15 ml of bupivacaine 0.25% for each side at the level of C6.

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient acceptance. * Age (21-60) years old. * Both sex * American Society of Anesthesiologist physical status I / II * Elective anterior cervical spine surgery under general anesthesia. * patient With Body Mass Index (BMI) (25-35kg/m²)

Exclusion criteria

* Local infection at site of puncture. * Altered mental status. * History of allergy to study drugs ( bupivacaine, fentanyl). * Patients with chronic pain. * Patients with severe hepatic or kidney impairment. * Patients having a history of hematological disorders, including coagulation abnormality.

Design outcomes

Primary

MeasureTime frameDescription
The time to first call to rescue analgesia24 hour postoperativeThe time to first call to rescue analgesia (nalbuphine) the time between the end of surgery to first report of postoperative pain. will be recorded.

Secondary

MeasureTime frameDescription
The total amount of nalbuphine24 hour postoperativeThe total amount of nalbuphine given to each patient during the first 24h of postoperative period will be recorded
Pain intensityup to 24hs postoperative2\. Pain intensity using Visual Analouge Scale (VAS) (11). A commonly used visual analog scale is a 10-cm line labeled with worst pain imaginable on the right border and no pain on the left border. The patient is instructed to make a mark along the line to represent the intensity of pain currently being experienced. VAS score will be assessed at 30 minutes, 2hs, 4hs, 6hs, 12hs, and 24hs postoperative and IV increment of 15mg nalbuphine (rescue analgesic) will be given if VAS≥4.
Total intra-operative fentanyl consumptionintra-operativeTotal intra-operative fentanyl consumption by ug excluding induction dose.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026